National Health Interview Survey

RWJBarnabas Health and Rutgers Health to Showcase Breakthrough Cardiology Data at the American College of Cardiology Scientific Session & Expo

Retrieved on: 
Monday, March 25, 2024

WEST ORANGE, N.J., March 25, 2024 /PRNewswire/ -- Physician-scientists from RWJBarnabas Health and Rutgers Health will present an extensive portfolio of innovative cardiovascular data from their clinical research program at the American College of Cardiology's (ACC) Annual Scientific Session & Expo in Atlanta, Georgia on April 6 to 8, 2024. A total of 59 abstracts have been accepted, composed of data evaluating and educating on risk factors, treatment options and ongoing research advances to improve cardiovascular care and outcomes for patients.

Key Points: 
  • A total of 59 abstracts have been accepted, composed of data evaluating and educating on risk factors, treatment options and ongoing research advances to improve cardiovascular care and outcomes for patients.
  • RWJBarnabas Health cardiac centers of excellence are nationally recognized for patient care and superior outcomes, including being named as one of Becker's top 100 Great Heart Programs in the country and recognized by American College of Cardiology as a Proven Quality Program.
  • Prior studies suggest that distinct patient subgroups with aortic stenosis may experience left ventricular systolic and diastolic dysfunction before the development of severe AS.
  • The study included patients who had received an angiogram done within 14 days of the CMR.

The Effect of Long COVID and Chronic Conditions on Employee Productivity and Disability Claims

Retrieved on: 
Monday, December 11, 2023

OAKLAND, Calif., Dec. 11, 2023 /PRNewswire/ -- The Integrated Benefits Institute (IBI), a health and productivity research non-profit, analyzed the impact of long COVID and certain chronic conditions on productivity, disability, and disability claims. The chronic conditions highlighted in the analysis include cancer, cardiovascular disease, diabetes, obesity, musculoskeletal, respiratory, and mental health conditions.

Key Points: 
  • US employees with long COVID along with certain comorbid conditions have a two-fold increase in missed workdays, according to Integrated Benefits Institute analysis
    OAKLAND, Calif., Dec. 11, 2023 /PRNewswire/ -- The Integrated Benefits Institute (IBI), a health and productivity research non-profit, analyzed the impact of long COVID and certain chronic conditions on productivity, disability, and disability claims.
  • The prevalence of long COVID has had a profound impact on disability claims, work absences, and healthcare expenses.
  • The study's findings shed light on the complex relationship that exists between long COVID, chronic conditions, and work-related outcomes.
  • Notably, 16% of these STD claims transitioned into LTD claims, resulting in 5,427 cases of long COVID LTD claims.

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

Retrieved on: 
Monday, November 20, 2023

CAMBRDIGE, Mass. and SECAUCUS, N.J., Nov. 20, 2023 /PRNewswire/ -- Universal DX ("UDX"), a biotech company on a mission to transform cancer into a curable disease, today announced a strategic collaboration with Quest Diagnostics ("Quest") (NYSE: DGX), the nation's leading provider of diagnostic information services, designed to improve colorectal cancer screening in the United States – for which more than 110 million people may be eligible.i

Key Points: 
  • Quest's oncology center of excellence in Lewisville, TX, will serve as the single site to support testing for the study.
  • A leader in advanced oncology diagnostics, Quest specializes in testing for inherited genetic disorders and tumor sequencing for colorectal and other cancers.
  • This collaboration will make it more likely that patients in the United States will, over time, have a convenient, quality and accessible option to screen for colorectal cancer."
  • "UDX has created a promising method of screening for colorectal cancer with a simple blood test that includes the ability to detect advanced adenomas.

PAX Debuts Novel, Science-Backed Product for Better Sleep

Retrieved on: 
Tuesday, November 7, 2023

PAX , a leading global cannabis brand, today announced the launch of Sleep by PAX, a first-of-its-kind, science-driven inhalable pod formula for the PAX Era platform.

Key Points: 
  • PAX , a leading global cannabis brand, today announced the launch of Sleep by PAX, a first-of-its-kind, science-driven inhalable pod formula for the PAX Era platform.
  • Sleep by PAX leverages a unique blend of cannabinoids and terpenes, developed to help consumers get to sleep faster, improve their sleep quality and ultimately get more restorative sleep.
  • Many Americans are sleep-deprived, which is having a significant impact on health and wellbeing,” said Brian Witlin, VP of Product Development at PAX.
  • Sleep by PAX is now available in a 1G pod format in Colorado starting at $40 and in Massachusetts starting at $60.

ADHD: inattention and hyperactivity have been the focus of research – but emotional problems may be the missing link

Retrieved on: 
Saturday, June 10, 2023

ADHD is diagnosed using criteria from a document called DSM-5, which include symptoms of inattention, hyperactivity and impulsivity.

Key Points: 
  • ADHD is diagnosed using criteria from a document called DSM-5, which include symptoms of inattention, hyperactivity and impulsivity.
  • But it is becoming increasingly clear to researchers that the condition also comes with self-control problems, affecting the ability to regulate emotions.
  • For example, 2.1% of children with a diagnosis of ADHD also have a mood disorder, such as depression, while 27.4% have an anxiety disorder.
  • Children with anxiety and depression symptoms only exhibited those deficits if they also had problems with attention.
  • So it seems that one possible route to helping children with ADHD or mood disorders with cognitive development is to focus on improving their attention.

Treatments

    • Methylphenidate roughly works by increasing three chemicals in the brain: dopamine, serotonin and noradrenaline.
    • Dopamine can improve attention, learning, working memory and motivation, while noradrenaline reduces impulsivity and boosts attention.
    • This research suggests that cognitive control, which is associated with frontal areas, can be improved by methylphenidate.
    • This should be offered to children with ADHD, in conjunction with pharmacological treatments.

ADHD on the rise

    • The number of ADHD diagnoses are rising across the world, and so are prescriptions of methylphenidate.
    • In the UK, a study estimated that the use of ADHD medications has increased by almost 800% from 2000 to 2015.
    • It may be that the prevalence of ADHD will increase even more in the future as coping strategies become less effective and people seek help and ultimately receive a diagnosis.
    • The more we learn about brain basis of ADHD, the easier it will get to treat.

Generic Drugs Global Market Report 2023: Growing Demand for Low-Cost Drugs Bolster Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 3, 2023

The Generic Drugs market is expected to continue growing in the coming years, driven by factors such as the increasing prevalence of chronic diseases, expiration of patent drugs, growing demand for low-cost drugs, and easy accessibility and supportive governments for allowing generic drugs in the market.

Key Points: 
  • The Generic Drugs market is expected to continue growing in the coming years, driven by factors such as the increasing prevalence of chronic diseases, expiration of patent drugs, growing demand for low-cost drugs, and easy accessibility and supportive governments for allowing generic drugs in the market.
  • Advancements in generic drugs have also contributed to the growth of the Generic Drugs market.
  • One of the biggest challenges the global generic drugs market is facing is ensuring the quality of generic drugs is the same as branded drugs.
  • This has led to increased demand for generic drugs in these regions, which has, in turn, contributed to the growth of the global generic drugs market.

The Fenway Institute finds disparities in health and health care access between sexual minorities and their heterosexual counterparts did not change from 2013-2018

Retrieved on: 
Tuesday, February 21, 2023

BOSTON, Feb. 21, 2023 /PRNewswire-PRWeb/ -- A research letter published today in JAMA Internal Medicine finds that differences in health status and health care access between sexual minorities and their heterosexual counterparts did not change from 2013 through 2018. Disparities persisted despite substantial policy, legislative, and sociocultural shifts recognizing the constitutional right to marriage equality and increasing public support for lesbian, gay, and bisexual (LGB) issues.

Key Points: 
  • The study found that nearly all subgroups of LGB adults in the United States reported higher levels of poor or fair health status, functional limitation, severe psychological distress, and difficulties with health care affordability than their heterosexual counterparts.
  • "Health inequities are driven by minority group stress and multifaceted societal marginalization.
  • "Health Status and Health Care Access Among Lesbian, Gay, and Bisexual Adults in the US, 2013-2018" was authored by researchers at The Fenway Institute, Fenway Health, Harvard Medical School, Massachusetts General Hospital, Harvard T.H.
  • Chan School of Public Health, and Vanderbilt University and contributes to the growing body of evidence demonstrating that societal marginalization is a persistent driver of health inequities.

Walgreens and Lexie Hearing Announce Availability of Over-the-Counter (OTC) Hearing Aids at Walgreens Stores Nationwide

Retrieved on: 
Thursday, October 6, 2022

Walgreens and Lexie Hearing today announced Lexie Lumen hearing aids will be available OTC at Walgreens stores nationwide for adults ages 18 and older with mild-to-moderate hearing loss starting October 17.

Key Points: 
  • Walgreens and Lexie Hearing today announced Lexie Lumen hearing aids will be available OTC at Walgreens stores nationwide for adults ages 18 and older with mild-to-moderate hearing loss starting October 17.
  • View the full release here: https://www.businesswire.com/news/home/20221006005319/en/
    Walgreens and Lexie Hearing announced Lexie Lumen hearing aids will be available over the counter at Walgreens stores nationwide for adults with mild-to-moderate hearing loss starting October 17.
  • Starting October 17, Lexie Lumen hearing aids can be purchased at Walgreens stores nationwide, including Puerto Rico, for $799.
  • Once purchased, Lexie Hearing offers customers a complete hearing solution, including a professional-quality hearing check, hearing aids customized to their unique hearing profile, and access to hearing experts through video or voice calls.

Survey: Why Are People Delaying Dental Care?

Retrieved on: 
Tuesday, August 23, 2022

LOS ANGELES, Aug. 23, 2022 /PRNewswire/ -- A nationwide survey released today by DentalInsurance.com revealed the reasons why Americans are delaying dental care even after dental offices have re-opened after COVID-19 closures. Over 1,214 adults across the United States were asked, "What issues have made you put off dental work?" Respondents had the option of selecting one or more of the following answers:

Key Points: 
  • One-in-five survey respondents (19.6 percent) indicated that this was a reason they had delayed dental care.
  • 13 percent gave fear of pain as a reason dental care was put off.
  • 9.5 percent of respondents postponed dental care because their dental plan did not cover the treatment and 4 percent reported care was delayed because their dentists were out-of-network.
  • One contributing factor to dental access problems for seniors is that Original Medicare does not include routine dental coverage.

The Onsite Foundation & Musicares® Announce a Strategic Partnership to Ensure Music Industry Professionals Receive Best-in-Class Emotional Health Education and Resources

Retrieved on: 
Wednesday, August 17, 2022

Last year, 26% of MusiCares Wellness in Music Survey respondents said they regularly experience moderate to severe levels of depression.

Key Points: 
  • Last year, 26% of MusiCares Wellness in Music Survey respondents said they regularly experience moderate to severe levels of depression.
  • The Onsite Foundation provides trauma-informed counseling and emotional health education that transforms individuals and communities.
  • The Onsite Foundation exists to ensure all persons affected by trauma, abuse, stress, or mental health issues receive the gift of emotional freedom.
  • Offering preventive, emergency, and recovery programs, MusiCares is a safety net supporting the health and welfare of the music community.